Abstract illustration representing rapid antibiotic resistance detection using chromatography.

Rapid Antibiotic Resistance Detection: A New TLC Method for Faster Treatment

"Combatting superbugs: How a novel thin layer chromatography (TLC) technique is speeding up the identification of beta-lactamase activity, including carbapenemases, to guide effective antibiotic use."


Beta-lactam antibiotics are essential for treating serious infections, but their effectiveness is threatened by the rise of beta-lactamase producing bacteria. These enzymes degrade beta-lactams, rendering them useless. As new beta-lactam antibiotics are introduced, bacteria evolve new beta-lactamases, creating a continuous challenge for healthcare.

Carbapenems, a type of beta-lactam, were once highly stable against beta-lactamases. However, the emergence of carbapenemases has led to widespread carbapenem resistance, posing a significant threat to public health. Rapid detection of carbapenemase production is crucial for determining carbapenem resistance and guiding appropriate treatment decisions.

Traditional methods for detecting carbapenemase production are time-consuming or complex. A new method called "Lactamaster", based on thin layer chromatography (TLC), offers a rapid and simple way to identify beta-lactamase activity, including carbapenemases, in clinical isolates. This method can determine their activity on different types of beta-lactam antibiotics within one hour.

AI Search Multiple angles on this topic

Why Conventional Detection Falls Short

Beta-lactamase is an enzyme secreted by bacteria and a principal resistance mechanism against beta-lactam antibiotics in Gram-negative bacteria. The activity of beta-lactamase can be evaluated to assess resistance, but traditional phenotypic detection remains time-consuming. Current antimicrobial-resistance methods, particularly culture-based approaches, also face limitations involving sensitivity, turnaround time, and the ability to detect all potential resistance genes.

How Does Lactamaster Work?

Abstract illustration representing rapid antibiotic resistance detection using chromatography.

The Lactamaster method relies on observing changes in the migration rate of beta-lactams in chromatography due to degradation by beta-lactamase enzymes. Bacterial isolates are incubated with beta-lactam antibiotics, and then the mixture is applied to a TLC plate. The plate is developed, and the antibiotics are visualized under UV light. If beta-lactamases are present, they will degrade the antibiotics, causing them to migrate differently on the plate.

Key features of the Lactamaster method:

  • Rapid: Results are available within one hour.
  • Simple: Easy to perform and interpret.
  • Versatile: Can detect a wide range of beta-lactamases, including carbapenemases.
  • Informative: Identifies which beta-lactam drugs are inactivated by the bacterial enzymes.
AI Search Multiple angles on this topic

TLC as a Rapid Beta-Lactamase Tool

A recent review identifies thin-layer chromatography as a rapid and simple technique for detecting beta-lactamases in clinical samples. It can also evaluate enzyme activity against several beta-lactam antibiotics, including carbapenems. Separately, research on Uncaria tomentosa endophytic-fungi extracts selected TLC because of its adsorption capability, illustrating the analytical property that motivated its use in that study.

Comparing Detection Platforms

The literature includes emerging electrochemical biosensors as alternatives to conventional antibiotic-resistance detection methods, although a 2026 review reports a significant gap in studies that systematically compare the two categories. Comparative guides describe PADAC-based assays as methods for detecting beta-lactamase activity and position them alongside other common approaches using experimental data and protocols. Separately, current work on carbapenemases emphasizes the challenge posed by metallo-beta-lactamases, which can confer resistance to nearly all beta-lactams while treatment options remain limited.

In a study, Lactamaster was used to screen 44 bacterial isolates, including 29 carbapenemase-producers and 15 non-carbapenemase-producers. The method accurately distinguished between the two groups with high sensitivity. It also provided information about the specific beta-lactam drugs inactivated by the enzymes.

The Potential Impact of Rapid Beta-Lactamase Detection

The Lactamaster method offers a valuable tool for guiding antimicrobial treatment, especially in critically ill patients infected with bacteria producing beta-lactamases. By rapidly identifying the presence and activity of these enzymes, clinicians can make more informed decisions about which antibiotics are likely to be effective.

AI Search Multiple angles on this topic

From Detection to Clinical Interpretation

Recent work describes beta-lactamase-producing Enterobacteriaceae as a critical challenge in diagnosing and managing antimicrobial resistance. In most laboratories, detection and characterization of extended-spectrum beta-lactamases is mandatory or strongly recommended because beta-lactamase-producing bacteria often carry broad resistance to first-line antibiotics. The Streck ARM-D Kit, beta-lactamase, was reported to detect a wide range of beta-lactamase genotypes at low upfront cost and to provide a comprehensive tool for key resistance genes of public-health concern in the United States.

Expanding the Rapid-Diagnostics Toolkit

Beta-lactamase enzymes hydrolyze the beta-lactam ring, reducing the affinity and effectiveness of beta-lactam antibiotics and reinforcing the need for improved therapeutic strategies. Current research directions in drug-resistant-bacteria detection include molecular biology, genomics, proteomics, nanotechnology, and bioinformatics. Emerging luminescence-based approaches include self-immobilizing fluorogenic probes, chemiluminescent relay systems, nanomaterial-based sensors, and AI-assisted mobile platforms.

Resistance Beyond a Single Test

Bacterial resistance remains a major therapeutic challenge, while beta-lactam antibiotics continue to be widely used against Enterobacteriaceae, including third-generation cephalosporins. Proposed strategies include immuno-antibiotics and targeting resistance-related pathways such as the SOS response and hydrogen sulfide networks. Other approaches use adjuvants that inactivate resistance enzymes, including beta-lactamases, or modify bacterial efflux pumps that expel antibiotics from cells.

Connecting Detection With Care

Clinical strategies for antimicrobial resistance may pair antibiotics with adjuvants that inhibit mechanisms such as beta-lactamases. Nonantibiotic partners, including immunomodulators and efflux-pump inhibitors, are also described as potential ways to improve outcomes. Real-world evidence is being used to reassess novel beta-lactams and support their appropriate place in therapy for multidrug-resistant Gram-negative infections.

While further validation is needed, Lactamaster holds promise for improving antibiotic stewardship and combating the spread of antibiotic resistance. Its simplicity and speed make it a practical option for clinical laboratories.

Future research will focus on determining the sensitivity of Lactamaster in different clinical isolates and exploring its potential for direct detection of beta-lactamases in clinical samples, such as urine or blood culture media.

The reported result supports using TLC migration changes to distinguish carbapenemase-producing from non-producing strains in the tested isolates. It does not establish how well that distinction would hold across other isolate sets or clinical settings.[1]

The method’s readout concerns whether beta-lactams are degraded and how they migrate; it is not, by itself, a classification of the specific carbapenemase involved.[1] [2]

How TLC compares with other rapid tests

A later review describes TLC as a rapid, simple way to detect beta-lactamases in clinical samples and assess activity against multiple beta-lactams, including carbapenems. Another later report chose TLC for adsorption in a separate analysis of fungal extracts; that rationale is not evidence of diagnostic performance.[3] [4]

  • Would the distinction reported in the tested isolates be maintained across a broader range of clinical isolates? The available result comes from a defined screening set, so its reach beyond that set remains unresolved.[1]
  • How would the migration-based result perform for metallo-beta-lactamases? A separate test evaluation links poor detection of these enzymes to insufficient zinc in its media, but does not establish whether that issue applies to TLC.[1] [2]

Terms used in the TLC evidence

Metallo-beta-lactamase (MBL)
A carbapenemase whose activity depends on zinc as a co-factor.[2]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.mimet.2018.11.016, Alternate LINK

Title: Rapid Detection Of Beta-Lactamase Production Including Carbapenemase By Thin Layer Chromatography

Subject: Microbiology (medical)

Journal: Journal of Microbiological Methods

Publisher: Elsevier BV

Authors: Zeynep Kanlidere, Onur Karatuna, Tanil Kocagöz

Published: 2019-01-01

Everything You Need To Know

1

What is the Lactamaster method?

The Lactamaster method is a novel approach utilizing thin layer chromatography (TLC) to quickly identify the presence of beta-lactamase enzymes in bacteria. These enzymes break down beta-lactam antibiotics, rendering them ineffective. Lactamaster visually detects this breakdown, providing a rapid assessment of beta-lactamase activity.

2

Why are beta-lactamases important?

Beta-lactamases are significant because they are enzymes produced by bacteria that break down beta-lactam antibiotics, a crucial class of drugs used to treat serious infections. The presence of these enzymes leads to antibiotic resistance, diminishing the effectiveness of these life-saving medications. The Lactamaster method helps identify these enzymes, which is crucial for choosing effective antibiotics. The development of carbapenemases, a type of beta-lactamase, has led to carbapenem resistance, posing a major threat to public health.

3

What are the implications of beta-lactamase activity?

The implications of beta-lactamase activity are substantial. When bacteria produce beta-lactamases, they can neutralize beta-lactam antibiotics, making them ineffective in treating infections. This leads to treatment failures, prolonged illnesses, and increased risk of complications. Rapid methods like Lactamaster are essential to quickly identify which antibiotics will be effective, thus improving patient outcomes and slowing the spread of antibiotic-resistant bacteria.

4

How does the Lactamaster method work?

Lactamaster works by exploiting the principle that beta-lactamase enzymes degrade beta-lactam antibiotics. In the Lactamaster method, bacterial isolates are incubated with beta-lactam antibiotics. This mixture is then applied to a thin layer chromatography (TLC) plate. After development, the TLC plate is examined under UV light. The change in the migration rate of the antibiotics on the TLC plate reveals whether the antibiotics were degraded by the bacterial enzymes. The presence of beta-lactamase activity will be evident by different migration patterns.

5

What are the advantages of the Lactamaster method?

The key benefits of the Lactamaster method include its speed, simplicity, versatility, and informative nature. Lactamaster provides results within one hour, making it a rapid diagnostic tool. It is easy to perform and interpret, making it accessible to various laboratories. It can detect a wide range of beta-lactamases, including carbapenemases. Lactamaster also identifies which specific beta-lactam drugs are inactivated by the bacterial enzymes. This information is invaluable for guiding antibiotic treatment decisions.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.